In my last blog post I told you that I decided to try the Medtronic 670g. Even though being on an insulin pump hadn’t improved my glycemic control in the previous 9 months, I still held out hope for this new pump. My insulin needs didn’t follow a pattern that either I or my doctors could get a handle on, and I was curious whether having the ‘hybrid closed loop system’ take over and make its own decisions minute by minute would do the trick.
My last post told you about my decision to go on an insulin pump after 13 years as a Type 1 with steadily rising A1Cs, scary low blood sugars, and frustrating highs. My timing couldn’t have been better. The Medtronic 670g – the world’s first FDA approved pump to use information from its continuous glucose monitor to make basal insulin adjustments – was on its way to market.
You’re standing on a winding trail at the precipice of a sheer cliff. The ocean crashes on the rocks below. Sidle up to the cliff and peek over the edge. Certain death. Look behind you, to the edge of a forest in the near distance. Hungry wolves with dripping jaws and glowing eyes wait, and watch.